CWD Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve 1) Un-audited Standalone Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CWD Ltd has scheduled a Board meeting on November 12, 2025 to approve its unaudited standalone and consolidated financial results for the half year ended September 30, 2025. The Board will also consider increasing the authorised share capital from ₹10 crore to ₹35 crore (a 3.5x expansion), which would require amendments to the Capital Clause of the Memorandum of Association subject to shareholder approval. Additionally, the Board plans to approve an Employee Stock Option Plan (ESOP) and authorise the NRC to act as the Compensation Committee for ESOP purposes. A bonus share issue to existing equity shareholders is also on the agenda, pending shareholder and other regulatory approvals. The trading window for dealing in the company's securities is currently closed and will reopen 48 hours after the Board meeting concludes.
This is a pre-results notice with several significant corporate actions lined up. If approved, the bonus issue, ESOP scheme, and large authorised capital expansion suggest the company may be preparing for future fundraising or growth, which could be seen as positive but also potentially dilutive. Investors should await the actual H1 FY26 results on November 12 for clarity on financial performance before drawing conclusions on stock price impact.